Published in J Biomol NMR on March 19, 2015
Computational studies of peptide-induced membrane pore formation. Philos Trans R Soc Lond B Biol Sci (2017) 0.78
Oligomerization of the antimicrobial peptide Protegrin-5 in a membrane-mimicking environment. Structural studies by high-resolution NMR spectroscopy. Eur Biophys J (2016) 0.75
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR (1992) 17.71
The Xplor-NIH NMR molecular structure determination package. J Magn Reson (2003) 16.23
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett (1993) 3.30
Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett (1995) 3.21
Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta (2006) 2.14
Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol (1996) 1.87
NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry (2008) 1.65
Biophysical approaches to membrane protein structure determination. Curr Opin Struct Biol (2001) 1.61
Solid-state NMR investigation of the depth of insertion of protegrin-1 in lipid bilayers using paramagnetic Mn2+. Biophys J (2003) 1.55
Solid-state NMR investigations of peptide-lipid interaction and orientation of a beta-sheet antimicrobial peptide, protegrin. Biochemistry (2002) 1.54
Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation. Proc Natl Acad Sci U S A (2005) 1.43
Defining the genetic relationship of protegrin-related sequences and the in vivo expression of protegrins. FEBS J (2014) 1.42
Membrane-bound dimer structure of a beta-hairpin antimicrobial peptide from rotational-echo double-resonance solid-state NMR. Biochemistry (2006) 1.41
Beyond NMR spectra of antimicrobial peptides: dynamical images at atomic resolution and functional insights. Solid State Nucl Magn Reson (2009) 1.33
Models of toxic beta-sheet channels of protegrin-1 suggest a common subunit organization motif shared with toxic alzheimer beta-amyloid ion channels. Biophys J (2008) 1.30
From innate immunity to de-novo designed antimicrobial peptides. Curr Pharm Des (2002) 1.29
Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett (1994) 1.22
The structure of porcine protegrin genes. FEBS Lett (1995) 1.19
Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptides. Biochemistry (2004) 1.18
Interaction of protegrin-1 with lipid bilayers: membrane thinning effect. Biophys J (2006) 1.18
Temperature-dependent transmembrane insertion of the amphiphilic peptide PGLa in lipid bilayers observed by solid state 19F NMR spectroscopy. J Am Chem Soc (2008) 1.10
Oligomerization of protegrin-1 in the presence of DPC micelles. A proton high-resolution NMR study. FEBS Lett (1998) 1.08
On the nature of antimicrobial activity: a model for protegrin-1 pores. J Am Chem Soc (2008) 1.07
Nitrogen-14 solid-state NMR spectroscopy of aligned phospholipid bilayers to probe peptide-lipid interaction and oligomerization of membrane associated peptides. J Am Chem Soc (2008) 1.04
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys (2004) 1.01
Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1. Biochemistry (2008) 1.01
Solution NMR studies of amphibian antimicrobial peptides: linking structure to function? Biochim Biophys Acta (2009) 1.01
Membrane lipid composition and the interaction of pardaxin: the role of cholesterol. Protein Pept Lett (2006) 1.01
Activity of protegrins against yeast-phase Candida albicans. Infect Immun (1998) 1.00
The role of solution NMR in the structure determinations of VDAC-1 and other membrane proteins. Curr Opin Struct Biol (2009) 1.00
Solid-state NMR studies of the structure, dynamics, and assembly of beta-sheet membrane peptides and alpha-helical membrane proteins with antibiotic activities. Acc Chem Res (2006) 0.98
Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochemistry (2005) 0.95
Structural characterization of the antimicrobial peptide pleurocidin from winter flounder. Biochemistry (2005) 0.93
Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect. BMC Struct Biol (2007) 0.93
Determination of solution structure and lipid micelle location of an engineered membrane peptide by using one NMR experiment and one sample. Biochim Biophys Acta (2007) 0.90
Structure of the Cdt1 C-terminal domain: conservation of the winged helix fold in replication licensing factors. Protein Sci (2009) 0.87
Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.87
The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial. J Oral Pathol Med (2011) 0.85
Membrane interactions and pore formation by the antimicrobial peptide protegrin. Biophys J (2013) 0.82
Dimerization of protegrin-1 in different environments. Int J Mol Sci (2010) 0.81
Solution structure of the Zbeta domain of human DNA-dependent activator of IFN-regulatory factors and its binding modes to B- and Z-DNAs. Proc Natl Acad Sci U S A (2011) 0.80
Oligomeric structure of a cathelicidin antimicrobial peptide in dodecylphosphocholine micelle determined by NMR spectroscopy. Biochim Biophys Acta (2010) 0.79
Molecular insight into mechanism of antimicrobial action of the beta-hairpin peptide arenicin: specific oligomerization in detergent micelles. Biopolymers (2008) 0.78
Use of a combination of the RDC method and NOESY NMR spectroscopy to determine the structure of Alzheimer's amyloid Aβ10-35 peptide in solution and in SDS micelles. Eur Biophys J (2013) 0.77
High-resolution NMR structure of the antimicrobial peptide protegrin-2 in the presence of DPC micelles. J Biomol NMR (2014) 0.77
Migraine associated with panic attacks. Cephalalgia (1999) 0.80
Blood flow velocity and pulsatility index differences in patients with unilateral migraine. Headache (2001) 0.78
High-resolution NMR structure of the antimicrobial peptide protegrin-2 in the presence of DPC micelles. J Biomol NMR (2014) 0.77
[Alternative pathways of nitric oxide formation in lactobacilli: EPR evidence for nitric oxide synthase activity]. Mikrobiologiia (2007) 0.77
Effects of calcium antagonists on serotonin-dependent aggregation and serotonin transport in platelets of patients with migraine. Bull Exp Biol Med (2000) 0.76
[The kinetic characteristics and stoichiometry of corticosterone interaction with cytosol receptors]. Fiziol Zh Im I M Sechenova (1993) 0.75
[Structure of amyloid-beta peptides in a complex with model membranes]. Tsitologiia (2014) 0.75
[The characteristics of the corticosteroid receptors in the hormonal modification of the stress reactivity of rats]. Fiziol Zh Im I M Sechenova (1995) 0.75
[Neuroses and autonomic disorders]. Zh Vyssh Nerv Deiat Im I P Pavlova (1977) 0.75
[An optical sensor for analyzing the flow of biological particles in chromatographic processes]. Lab Delo (1989) 0.75
[Emotional and personality aspects of the pathogenesis of atopic dermatitis]. Vestn Dermatol Venerol (1988) 0.75
[Treatment of various forms of tense headaches by biofeedback]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75
[The dynamics of the species composition of nidiculous animals in different types of nests of the little suslik]. Parazitologiia (1995) 0.75
[The comparative results of pharmacotherapy in migraine]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.75
[Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine]. Biull Eksp Biol Med (1998) 0.75
[Migraine: dynamics of psychophysiologic pattern]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75
[Autonomic paroxysms]. Klin Med (Mosk) (1968) 0.75
[Clinico-neurophysiological correlations in migraine]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.75
[The properties of the glucocorticoid receptors in the striatum and hypothalamus of rats selected for the threshold of excitability of their nervous systems]. Fiziol Zh Im I M Sechenova (1994) 0.75
[Effect of meteo- and heliofactors on the state of the autonomic nervous system and the adaptive capacity of man (review)]. Zh Nevropatol Psikhiatr Im S S Korsakova (1987) 0.75
[The role of hyperventilation and neuromuscular excitability in the clinical picture and pathogenesis of migraine headaches]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.75
[Characterizing influenza virus suspensions by determining the spectrum of turbidity]. Vopr Virusol (1984) 0.75
Structure of pravastatin and its complex with sodium dodecyl sulfate micelles studied by NMR spectroscopy. Magn Reson Chem (2014) 0.75
[Gender differences in migraine and wake-sleep migraine attacks]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.75
[Autonomic dystonia syndrome]. Klin Med (Mosk) (1974) 0.75
[Psycho-autonomic interrelationships in the pathology of various links in the limbic-reticular complex]. Zh Nevropatol Psikhiatr Im S S Korsakova (1973) 0.75
Dynamic NMR study of cyclic derivatives of pyridoxine. Magn Reson Chem (2014) 0.75
[The psychoemotional aspects of the pathogenesis of androgenetic alopecia in women]. Vestn Dermatol Venerol (1990) 0.75
[The epidemiology of autonomic disorders--the autonomic dystonia syndrome--and its characteristics in cerebrovascular pathology]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75
[Sumatriptan in the treatment of cluster headache and migraine attacks]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.75
[The tension headache]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.75
[Features of the regulation of autonomic nervous system functions in various paroxysmal states of cerebral origin]. Zh Nevropatol Psikhiatr Im S S Korsakova (1987) 0.75
[Chronic posttraumatic headache in juveniles]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75
[Thermography in healthy subjects and in the syndrome of vegetative-vascular dystonia]. Zh Nevropatol Psikhiatr Im S S Korsakova (1985) 0.75
[Current aspects of the clinical course and pathogenesis of migraine (review of the literature)]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75
[Aura migraine]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75
[The autonomic dystonia syndrome]. Feldsher Akush (1988) 0.75
[Polygraphic structure of sleep and personality characteristics]. Sov Med (1975) 0.75
[Clinical and psychophysiological characteristics of headache in childhood]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75
[Effect of concentration amplification in artificial phospholipid membranes]. Biofizika (1971) 0.75
[Acetylsalicylic acid in therapy of migraine]. Zh Nevrol Psikhiatr Im S S Korsakova (1998) 0.75
[The dynamics of the microbiocenosis in the burrows of the little suslik]. Parazitologiia (1994) 0.75
[Trigeminal evoked potentials in migraine]. Zh Nevrol Psikhiatr Im S S Korsakova (1998) 0.75
[The evaluation of corticosteroid hormone receptor status in the brain structures of stressed and adrenalectomized rats]. Fiziol Zh Im I M Sechenova (1995) 0.75
[Clinical and psychological characteristics and therapy of patients with cluster (bunch) headache]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75
[Role of neurogenic factors in the genesis of somatic diseases]. Ter Arkh (1974) 0.75
Changes in the nitrocellulose molecule induced by sulfate-reducing bacteria Desulfovibrio desulfuricans 1,388. The enzymes participating in this process. Biochemistry (Mosc) (2004) 0.75
[Clinical and psychological analysis of migraine population]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75
[The tension headache]. Zh Nevrol Psikhiatr Im S S Korsakova (1995) 0.75
[The classification of headache]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.75
[NMR screening of potential inhibitors of Citrobacter freundii methionine]. Mol Biol (Mosk) (2015) 0.75
[Stabilization of suspensions of the influenza virus using human serum albumin]. Vopr Virusol (1990) 0.75
[The glucocorticoid receptors in the hippocampus of rats with different excitabilities of the nervous system]. Fiziol Zh Im I M Sechenova (1994) 0.75
[The development of autonomic regulation in the virtually healthy human subject]. Zh Nevropatol Psikhiatr Im S S Korsakova (1988) 0.75
[Unusual alternations of floral organs in Paeonia: structure and possible mechanism of formation]. Ontogenez (2008) 0.75
[Clinico-psychophysiological characteristics of lateralized forms of migraine]. Zh Nevropatol Psikhiatr Im S S Korsakova (1989) 0.75
[Psychoemotional condition and autonomic nervous system in patients suffering from myocardial infarction in the young age]. Sov Med (1991) 0.75
[Clinical aspects and treatment of migraine]. Sov Med (1991) 0.75